| 1 |
35106936 |
10.1002/cam4.4550 |
2022 |
SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups. |
CIITA |
| 2 |
35760800 |
10.1038/s41467-022-31356-7 |
2022 |
Osteocyte CIITA aggravates osteolytic bone lesions in myeloma. |
CIITA |
| 3 |
33777766 |
10.3389/fonc.2021.620435 |
2021 |
Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. |
CIITA |
| 4 |
34360767 |
10.3390/ijms22158001 |
2021 |
HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models. |
CIITA |
| 5 |
34925435 |
10.3389/fgene.2021.677650 |
2021 |
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. |
CIITA |
| 6 |
32002294 |
10.1080/2162402X.2019.1683346 |
2020 |
Epstein-Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppression. |
CIITA |
| 7 |
32555149 |
10.1038/s41408-020-0335-0 |
2020 |
CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. |
CIITA |
| 8 |
32649887 |
10.1016/j.ccell.2020.06.002 |
2020 |
Immunogenomic Landscape of Hematological Malignancies. |
CIITA |
| 9 |
32947237 |
10.1016/j.tranon.2020.100855 |
2020 |
Identification of clinical molecular targets for childhood Burkitt lymphoma. |
CIITA |
| 10 |
30211726 |
10.1097/PAS.0000000000001154 |
2019 |
Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease. |
CIITA |
| 11 |
30540571 |
10.1097/PAS.0000000000001198 |
2019 |
Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA. |
CIITA |
| 12 |
31292115 |
10.1182/blood.2019001126 |
2019 |
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. |
CIITA |
| 13 |
31704289 |
10.1016/j.intimp.2019.105999 |
2019 |
Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma. |
CIITA |
| 14 |
31783769 |
10.1186/s12977-019-0498-6 |
2019 |
Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1. |
CIITA |
| 15 |
29289361 |
10.1016/j.blre.2017.12.001 |
2018 |
The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies. |
CIITA |
| 16 |
29857068 |
10.1016/j.jid.2018.04.038 |
2018 |
Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. |
CIITA |
| 17 |
28479318 |
10.1016/j.jid.2017.04.010 |
2017 |
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. |
CIITA |
| 18 |
26500140 |
10.1038/leu.2015.299 |
2016 |
FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas. |
CIITA |
| 19 |
26758422 |
10.3109/10428194.2015.1135431 |
2016 |
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520. |
CIITA |
| 20 |
26792751 |
10.1128/JVI.03000-15 |
2016 |
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein. |
CIITA |
| 21 |
26850007 |
10.1002/gcc.22345 |
2016 |
Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies. |
CIITA |
| 22 |
25393674 |
10.3109/10428194.2014.985673 |
2015 |
Structural genomic alterations in primary mediastinal large B-cell lymphoma. |
CIITA |
| 23 |
25631773 |
10.1182/blood-2014-08-594689 |
2015 |
Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1. |
CIITA |
| 24 |
25712539 |
10.1002/path.4522 |
2015 |
Recurrent genomic rearrangements in primary testicular lymphoma. |
CIITA |
| 25 |
25713363 |
10.1073/pnas.1501199112 |
2015 |
Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. |
CIITA |
| 26 |
26049756 |
10.1097/MOH.0000000000000155 |
2015 |
Genomic alterations underlying immune privilege in malignant lymphomas. |
CIITA |
| 27 |
26135560 |
10.1097/PAS.0000000000000473 |
2015 |
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling. |
CIITA |
| 28 |
26229090 |
10.1158/2159-8290.CD-15-0370 |
2015 |
Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. |
CIITA |
| 29 |
26314988 |
10.1038/bcj.2015.69 |
2015 |
Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma. |
CIITA |
| 30 |
26549456 |
10.1016/j.celrep.2015.10.008 |
2015 |
Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression. |
CIITA |
| 31 |
26599546 |
10.1371/journal.pone.0139663 |
2015 |
Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines. |
CIITA |
| 32 |
23449805 |
10.1128/JVI.00250-13 |
2013 |
Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis. |
CIITA |
| 33 |
23770291 |
10.1016/j.cellsig.2013.06.007 |
2013 |
Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. |
CIITA |
| 34 |
23789844 |
10.1111/imm.12136 |
2013 |
Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma. |
CIITA |
| 35 |
22532676 |
10.1128/JVI.06908-11 |
2012 |
Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3. |
CIITA |
| 36 |
22808135 |
10.1371/journal.pone.0040332 |
2012 |
Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma. |
CIITA |
| 37 |
23251452 |
10.1371/journal.pone.0051203 |
2012 |
New fusion transcripts identified in normal karyotype acute myeloid leukemia. |
CIITA |
| 38 |
21345951 |
10.1128/JVI.02123-10 |
2011 |
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression. |
CIITA |
| 39 |
21368758 |
10.1038/nature09754 |
2011 |
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. |
CIITA |
| 40 |
21664896 |
10.1016/j.bcp.2011.05.026 |
2011 |
Epigenetic regulation of CIITA expression in human T-cells. |
CIITA |
| 41 |
21822207 |
10.1038/modpathol.2011.116 |
2011 |
Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. |
CIITA |
| 42 |
20363966 |
10.4049/jimmunol.1000079 |
2010 |
PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA. |
CIITA |
| 43 |
19081173 |
10.1016/j.exphem.2008.10.001 |
2009 |
Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL). |
CIITA |
| 44 |
19229048 |
10.3324/haematol.2008.000752 |
2009 |
CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression. |
CIITA |
| 45 |
19814686 |
10.3109/10428190903297531 |
2009 |
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV. |
CIITA |
| 46 |
19863170 |
10.3109/10428190903350454 |
2009 |
MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise? |
CIITA |
| 47 |
17312329 |
10.1200/JCO.2006.09.3534 |
2007 |
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. |
CIITA |
| 48 |
16239429 |
10.1182/blood-2005-04-1510 |
2006 |
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions. |
CIITA |
| 49 |
16337482 |
10.1016/j.molimm.2005.03.008 |
2006 |
Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression. |
CIITA |
| 50 |
14563641 |
10.1182/blood-2003-05-1491 |
2004 |
Regulation of MHC class II expression in human T-cell malignancies. |
CIITA |
| 51 |
14973505 |
10.1038/sj.leu.2403315 |
2004 |
Defective class II transactivator expression in a B lymphoma cell line. |
CIITA |
| 52 |
15384976 |
10.1111/j.1365-2141.2004.05151.x |
2004 |
Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas. |
CIITA |
| 53 |
12738680 |
10.1182/blood-2002-08-2482 |
2003 |
BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. |
CIITA |
| 54 |
12887826 |
|
2003 |
[Cloning and biological activities of riboenzymes against major histocompatibility complex class II transactivator]. |
CIITA |
| 55 |
11802213 |
10.1002/ijc.1623 |
2002 |
Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines. |
CIITA |
| 56 |
12218125 |
10.4049/jimmunol.169.6.3085 |
2002 |
DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells. |
CIITA |
| 57 |
12391224 |
10.4049/jimmunol.169.9.5078 |
2002 |
Modulation of gene expression by the MHC class II transactivator. |
CIITA |
| 58 |
12492813 |
10.1034/j.1399-0039.2002.600504.x |
2002 |
Class II transactivator-induced expression of HLA-DO(beta) in HeLa cells. |
CIITA |
| 59 |
10637510 |
10.1038/sj.onc.1203293 |
1999 |
Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples. |
CIITA |
| 60 |
10725870 |
10.1002/(sici)1099-1069(199912)17:4<149::aid-hon645>3.0.co;2-f |
1999 |
Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells. |
CIITA |
| 61 |
9722631 |
10.1093/nar/26.18.4128 |
1998 |
The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element. |
CIITA |
| 62 |
9177216 |
10.1073/pnas.94.12.6324 |
1997 |
Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. |
CIITA |
| 63 |
9177217 |
10.1073/pnas.94.12.6330 |
1997 |
Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. |
CIITA |
| 64 |
9234682 |
10.1128/MCB.17.8.4249 |
1997 |
Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy. |
CIITA |
| 65 |
9352360 |
10.1093/intimm/9.10.1545 |
1997 |
Suppression of MHC class II expression by human class II trans-activator constructs lacking the N-terminal domain. |
CIITA |
| 66 |
8666795 |
|
1996 |
Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells. |
CIITA |
Datasets
Models
